| Literature DB >> 31673343 |
Kerri Wazny1,2, Narendra K Arora3,2, Archisman Mohapatra3, Hema S Gopalan3, Manoj K Das3, Mkc Nair4, Sandeep Bavdekar5, Reeta Rasaily6, Vasantha Thavaraj6, Malabika Roy6, Chander Shekhar6, Rakesh Kumar6, Vishwa M Katoch6, Igor Rudan1, Robert E Black7, Soumya Swaminathan8.
Abstract
BACKGROUND: Millennium Development Goal 4 (MDGs) mobilised countries to reduce child mortality by two thirds the 1990 rate in 2015. While India did not reach MDG 4, it considerably reduced child mortality in the MDG-era. Efficient and targeted interventions and adequate monitoring are necessary to further progress in improvements to child health. Looking forward to the Sustainable Development Goal (SDG)-era, the Indian Council of Medical Research and The INCLEN Trust International conducted a national research priority setting exercise for maternal, child, newborn health, and maternal and child nutrition. Here, results are reported for child health.Entities:
Mesh:
Year: 2019 PMID: 31673343 PMCID: PMC6818639 DOI: 10.7189/jogh.09.020701
Source DB: PubMed Journal: J Glob Health ISSN: 2047-2978 Impact factor: 4.413
Gender and age distribution of scorers nationally and regionally
| Characteristic | National (N = 233) | Empowered Action Group and North Eastern States (N = 69) | Northern States and Union Territories (N = 68) | Southern and Western States and Union Territories (N = 96) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FEMALE | 22 | 22 | 23 | 20 | 27 | 57 | 5 | 7 | 6 | 2 | 8 | 14 | 6 | 8 | 6 | 3 | 9 | 16 | 11 | 7 | 11 | 15 | 10 | 27 | |
| MALE | 77 | 67 | 65 | 83 | 60 | 176 | 24 | 18 | 21 | 25 | 22 | 55 | 24 | 22 | 18 | 23 | 17 | 52 | 29 | 27 | 26 | 35 | 21 | 69 | |
| Mean ± SD | 48.42 ± 11.05 | 50.19 ± 10.52 | 49.49 ± 10.13 | 46.39 ± 11.81 | |||||||||||||||||||||
| Median (IQR) | 50(18) | 52(17) | 51(17) | 45.5(22) | |||||||||||||||||||||
| Min-Max | 28-71 | 29-71 | 31-71 | 28-71 | |||||||||||||||||||||
ANS – answerability, EQU – equity, REL – relevance, INN – innovation, INV – innovation and out-of-box thinking and investment in research, SD – standard deviation, IQR – inter-quartile range, Min-Max – minimum-maximum
Top 10 Research Priorities for Child Health in India, Nationally, by domain and with ranks, unweighted scores* in each criterion, overall weighted research priority scores (wRPS)*, and Average Expert Agreement (AEA)
| National Rank | Research priority | Domain(s) | Relevance | Answerability | Equity | Innovation | Investment in Research | National wRPS | AEA |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Develop locally relevant cost-effective strategies to expand the coverage of universal immunisation program (UIP) by reaching segments of populations that are traditionally left out (address system1 and community2 challenges) | Dev | 0.94 | 0.95 | 0.99 | 0.84 | 0.88 | 0.92 | 0.92 |
| 1Vaccine preventable diseases (VPD) epidemiology, system capacity, cold chain, safety surveillance | |||||||||
| 2Hesitancy, drop-out, outreach strategies, knowledge, attitudes, and practices (KAP) of care provider, community and clients | |||||||||
| 2. | Improving administrative data quality and strengthening data-driven child health program monitoring, action, and accountability and primary health care (PHC) and district levels (eg, line listing of households with children with neuro-developmental disability (NDD), use of information and communication technologies (ICT), develop novel indicators). | Del | 0.90 | 1.00 | 0.94 | 0.84 | 0.94 | 0.92 | 0.92 |
| 3. | Development and validation of low-cost technologies for screening, referral, and management of childhood pneumonia and acute respiratory infections (ARI) in the community and at various levels of health care (eg, mHealth, point-of-care diagnostics & therapeutics, management protocols, etc.). | Dev. & Del. | 0.92 | 0.98 | 0.93 | 0.88 | 0.86 | 0.92 | 0.92 |
| 4. | Strategies to promote water, sanitation, and hygiene practices in the community to improve child health and nutrition. | Del. | 0.93 | 1.00 | 0.89 | 0.88 | 0.85 | 0.92 | 0.91 |
| 5. | Development of cost-effective, feasible, validated point-of-care diagnostics for malaria in children for use at community and different levels of health care. | Dev. & Del | 0.97 | 0.95 | 0.93 | 0.84 | 0.85 | 0.92 | 0.91 |
| 6. | Development of evidence-based guidelines for rational use of antibiotics for childhood morbidities in India: choice of antibiotics; route and delivery systems (eg, nebulizers); duration of therapy; monitoring criteria; adjunct therapies. | Dev. | 0.96 | 0.99 | 0.83 | 0.87 | 0.91 | 0.91 | 0.91 |
| 7. | Development of an integrated child health program for improving quality of life of children: challenges and barriers; strategies to overcome; feasibility across the country; effectiveness; cost-effectiveness. | Dev. & Del. | 0.93 | 0.96 | 0.92 | 0.91 | 0.78 | 0.91 | 0.90 |
| 8. | Establishing an effective and sustainable VPD surveillance program (especially measles and rubella, pneumonia and diarrhoea) in India [eg, defining syndromes (fever and rash) and program thresholds, forging public private partnerships (PPPs), building upon polio infrastructure, using technology such as mHealth, GIS, etc.). | Del. | 0.92 | 0.97 | 0.91 | 0.87 | 0.84 | 0.91 | 0.90 |
| 9. | Identifying cost-effective strategies for supplementation of micronutrients and probiotics to prevent and control childhood diarrhoea, pneumonia and other infections. | Del. | 0.91 | 0.98 | 0.91 | 0.85 | 0.85 | 0.90 | 0.90 |
| 10. | To establish a nation-wide multicentric antimicrobial surveillance and antibiotic stewardship program for infectious morbidities during childhood. | Del. | 0.97 | 0.94 | 0.82 | 0.89 | 0.85 | 0.90 | 0.89 |
ANS – answerability, EQU – equity, REL – relevance, INN – innovation, INV – innovation and out-of-box thinking and investment in research, SD – standard deviation, IQR – inter-quartile range, Min-Max – minimum-maximum, Del – delivery, Dev – development, Disc – discovery, Desc – description
*Unweighted scores presented to explore researchers’ prioritisation and optimism of criteria relative to research priorities prior to weights being applied.
†Weighted RPS (wRPS) calculated by applying Larger Reference Group (LRG) weights (relevance = 0.254; answerability = 0.192; equity = 0.194; innovation and out of box thinking = 0.199; investment in research = 0.161) to unweighted scores and adding.
Top 10 Research Priorities for Child Health in the Empowered Action Group and North-Eastern states, by domain and with regional ranks, unweighted scores* in each criterion, weighted research priority scores (wRPS), and average expert agreement (AEA)
| Regional rank | Research priority | Domain(s) | Relevance | Answerability | Equity | Innovation | Investment in research | Regional wRPS | AEA |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Undertake systematic child health policy analysis for identifying strengths and gaps and developing policy guidance to meet the Sustainable Development Goals (SDGs). | Desc & Del | 1.00 | 1.00 | 1.00 | 0.93 | 0.95 | 0.98 | 0.98 |
| 2. | Improving administrative data quality and strengthening data-driven child health program monitoring, action, and accountability and primary health centres (PHC) and district levels (eg, line listing of households with children with neuro-developmental delay (NDD), use of information communication technologies (ICT), develop novel indicators). | Del | 0.94 | 1.00 | 0.95 | 0.95 | 1.00 | 0.96 | 0.97 |
| 3. | Development of evidence-based guidelines for rational use of antibiotics for childhood morbidities in India: choice of antibiotics; route and delivery systems (eg, nebulizers); duration of therapy; monitoring criteria; adjunct therapies. | Dev | 1.00 | 1.00 | 0.81 | 1.00 | 0.96 | 0.96 | 0.95 |
| 4. | Development of cost-effective, feasible, validated point-of-care diagnostics for malaria in children for use at community and different levels of health care. | Dev & Del | 1.00 | 0.96 | 0.95 | 0.96 | 0.85 | 0.95 | 0.94 |
| 5. | Development of portable water purifiers and recyclers for generating potable water and household levels. | Dev | 0.94 | 1.00 | 0.95 | 0.94 | 0.91 | 0.95 | 0.95 |
| 6. | Integrate, revise, and evaluate curriculums for comprehensive skill building and their retention for health personnel involved in child health and nutrition services and all levels of care. | Del | 0.95 | 1.00 | 0.86 | 0.95 | 0.95 | 0.94 | 0.94 |
| 7. | Development and validation of low-cost technologies for screening, referral, and management of childhood pneumonia and ARI in the community and at various levels of health care (eg, mHealth, point-of-care diagnostics & therapeutics, management protocols, etc.). | Dev | 0.91 | 1.00 | 1.00 | 0.92 | 0.88 | 0.94 | 0.94 |
| 8. | Impact, process, and economic evaluation of the National Vector Borne Disease Control Program in the context of improving child health. | Del | 0.95 | 0.96 | 0.90 | 0.90 | 1.00 | 0.94 | 0.94 |
| 9. | Identifying barriers and strategies to overcome and achieve Indian Public Health Standards (IPHS) benchmarks at primary and secondary level health facilities. | Desc& Del | 0.88 | 1.00 | 0.94 | 1.00 | 0.90 | 0.94 | 0.94 |
| 10. | Strategies to engage the community and its resources (organizations, personnel) in improving the quality and outcome of the community-based management of childhood morbidities. | Dev | 0.89 | 1.00 | 0.91 | 0.96 | 0.95 | 0.94 | 0.94 |
ANS – answerability, EQU – equity, REL – relevance, INN – innovation, INV – innovation and out-of-box thinking and investment in research, SD – standard deviation, IQR – inter-quartile range, Min-Max – minimum-maximum, Del – delivery, Dev – development, Disc – discovery, Desc – description
*Unweighted scores presented to explore researchers’ prioritisation and optimism of criteria relative to research priorities prior to weights being applied.
†Weighted RPS (wRPS) calculated by applying Larger Reference Group (LRG) weights (relevance = 0.254; answerability = 0.192; equity = 0.194; innovation and out of box thinking = 0.199; investment in research = 0.161) to unweighted scores and adding.
Top 10 Research Priorities for Child Health in the Northern states and Union Territories, by domain and with regional ranks and unweighted scores* in each criterion, weighted research priority scores (wRPS), and average expert agreement (AEA)
| Regional rank | Research priority | Domain(s) | Relevance | Answerability | Equity | Innovation | Investment in research | Regional wRPS | AEA |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Development and validation of low-cost technologies for screening, referral, and management of childhood pneumonia and acute respiratory infection (ARI) in the community and at various levels of health care (eg, mHealth, point-of-care diagnostics & therapeutics, management protocols, etc.). | Dev | 0.95 | 0.96 | 0.92 | 0.95 | 0.91 | 0.94 | 0.94 |
| 2. | Identifying interventions to prevent/minimize development of adverse cardiometabolic and neurodevelopmental outcomes in low birthweight (LBW) [preterm and small for gestational age (SGA)] babies. | Dev | 1.00 | 1.00 | 0.89 | 0.88 | 0.84 | 0.93 | 0.92 |
| 3. | Development of cost-effective, feasible, validated point-of-care diagnostics for malaria in children for use at community and different levels of health care. | Dev & Del | 1.00 | 0.92 | 0.96 | 0.74 | 0.91 | 0.91 | 0.91 |
| 4. | Developing novel, cost-effective therapeutic regimens for treatment of resistant childhood malaria. | Dev | 0.89 | 0.96 | 0.90 | 0.90 | 0.89 | 0.91 | 0.91 |
| 5. | Impact of Artemisinin Combination Therapy on malaria disease epidemiology and resistance patterns in India. | Del | 0.95 | 1.00 | 1.00 | 0.68 | 0.89 | 0.91 | 0.90 |
| 6. | Identifying effective communication strategies (messages and channels) to improve awareness on child care and feeding practices during illness. | Dev & Del | 0.95 | 0.92 | 0.88 | 0.91 | 0.83 | 0.90 | 0.90 |
| 7. | Development of an integrated child health program for improving quality of life of children: challenges and barriers; strategies to overcome; feasibility across the country; effectiveness; cost-effectiveness. | Dev & Del | 0.90 | 1.00 | 0.92 | 0.86 | 0.83 | 0.90 | 0.90 |
| 8. | Develop locally relevant cost-effective strategies to expand the coverage of universal immunisation program (UIP) by reaching segments of populations that are traditionally left out (address system1 and community2 challenges): | Dev | 0.90 | 0.96 | 0.96 | 0.78 | 0.91 | 0.90 | 0.90 |
| 1Vaccine preventable diseases (VPD) epidemiology, system capacity, cold chain, safety surveillance | |||||||||
| 2hesitancy, drop-out, outreach strategies, knowledge, attitudes, and practices (KAP) of care provider, community and clients | |||||||||
| 9. | Establishing an effective and sustainable VPD surveillance program (especially measles and rubella, pneumonia and diarrhoea) in India (eg, defining syndromes (fever and rash) and program thresholds, forging public private partnerships (PPPs), building upon polio infrastructure, using technology such as mHealth, GIS, etc.). | Del | 0.90 | 0.96 | 0.88 | 0.91 | 0.83 | 0.90 | 0.90 |
| 10. | Improving diarrhoea control strategies in the public health system (eg,, oral rehydration solutions (ORS), zinc, water and sanitation hygiene (WASH), rational antibiotic and drug use). | Del | 0.91 | 1.00 | 0.96 | 0.78 | 0.83 | 0.90 | 0.90 |
ANS – answerability, EQU – equity, REL – relevance, INN – innovation, INV – innovation and out-of-box thinking and investment in research, SD – standard deviation, IQR – inter-quartile range, Min-Max – minimum-maximum, Del – delivery, Dev – development, Disc – discovery, Desc – description
*Unweighted scores presented to explore researchers’ prioritisation and optimism of criteria relative to research priorities prior to weights being applied.
†Weighted RPS (wRPS) calculated by applying Larger Reference Group (LRG) weights (relevance = 0.254; answerability = 0.192; equity = 0.194; innovation and out of box thinking = 0.199; investment in research = 0.161) to unweighted scores and adding.
Top 10 Research Priorities for Child Health in the Southern and Western states and Union territories, by domain and with regional ranks, unweighted scores± in each criterion, weighted research priority scores (wRPS), and average expert agreement (AEA)
| Regional rank | Research priority | Domain(s) | Relevance | Answerability | Equity | Innovation | Investment in research | Regional wRPS | AEA |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Develop locally relevant cost-effective strategies to expand the coverage of universal immunisation program (UIP) by reaching segments of populations that are traditionally left out (address system1 and community2 challenges): | Dev | 1.00 | 0.92 | 1.00 | 0.85 | 0.86 | 0.93 | 0.93 |
| 1Vaccine preventable diseases (VPD) epidemiology, system capacity, cold chain, safety surveillance | |||||||||
| 2Hesitancy, drop-out, outreach strategies, knowledge, attitudes, practices (KAP) of care provider, community and clients | |||||||||
| 2. | Strategies to promote water, sanitation, and hygiene practices in the community to improve child health and nutrition. | Del | 1.00 | 1.00 | 0.90 | 0.89 | 0.81 | 0.93 | 0.92 |
| 3. | Improving administrative data quality and strengthening data-driven child health program monitoring, action, and accountability and primary health centres (PHC) and district levels (eg, line listing of households with children with neuro-developmental delays (NDD), use of information communication technologies (ICT), develop novel indicators). | Del | 0.93 | 1.00 | 0.92 | 0.84 | 0.95 | 0.93 | 0.93 |
| 4. | Impact evaluation of the universal immunisation program (UIP) with particular emphasis of recently introduced vaccines (eg, pentavalent measles, supplementary immunisation activities (SIAs), etc.) | Del | 0.97 | 0.97 | 0.90 | 0.87 | 0.83 | 0.91 | 0.91 |
| 5. | Improving diarrhoea control strategies in the public health system (eg, oral rehydration solution (ORS), zinc, water and sanitation hygiene (WASH), rational antibiotic and drug use). | Del | 0.94 | 0.97 | 0.87 | 0.83 | 0.93 | 0.91 | 0.91 |
| 6. | Development of an integrated child health program for improving quality of life of children: challenges and barriers; strategies to overcome; feasibility across the country; effectiveness; cost-effectiveness. | Dev & Del | 1.00 | 0.89 | 0.96 | 0.89 | 0.75 | 0.91 | 0.90 |
| 7. | Identifying novel low-cost environmentally friendly strategies for control of vectors. | Dev | 0.93 | 0.91 | 0.92 | 0.90 | 0.86 | 0.91 | 0.90 |
| 8. | Establishing an effective and sustainable VPD surveillance program (especially measles and rubella, pneumonia and diarrhoea) in India (eg, defining syndromes (fever and rash) and program thresholds, forging public private partnerships (PPPs), building upon polio infrastructure, using technology such as mHealth, GIS, etc.). | Del | 0.94 | 0.94 | 0.90 | 0.87 | 0.85 | 0.90 | 0.90 |
| 9. | Strategies to engage the community and its resources (organizations, personnel) in improving the quality and outcome of the community-based management of childhood morbidities. | Dev | 0.90 | 0.91 | 0.96 | 0.84 | 0.90 | 0.90 | 0.90 |
| 10. | Identifying cost-effective strategies for supplementation of micronutrients and probiotics to prevent and control childhood diarrhoea, pneumonia, and other infections. | Del | 0.91 | 0.94 | 0.89 | 0.91 | 0.85 | 0.90 | 0.90 |
ANS – answerability, EQU – equity, REL – relevance, INN – innovation, INV – innovation and out-of-box thinking and investment in research, SD – standard deviation, IQR – inter-quartile range, Min-Max – minimum-maximum, Del – delivery, Dev – development, Disc – discovery, Desc – description
*Unweighted scores presented to explore researchers’ prioritisation and optimism of criteria relative to research priorities prior to weights being applied.
†Weighted RPS (wRPS) calculated by applying Larger Reference Group (LRG) weights (relevance = 0.254; answerability = 0.192; equity = 0.194; innovation and out of box thinking = 0.199; investment in research = 0.161) to unweighted scores and adding.
Top 20 national research priorities with regional ranks
| Priority research option | Rank | |||
|---|---|---|---|---|
| Develop locally relevant cost-effective strategies to expand the coverage of universal immunisation program (UIP) by reaching segments of populations that are traditionally left out (address system1 and community2 challenges): | 1 | 11 | 8 | 1 |
| 1Vaccine preventable diseases (VPD) epidemiology, system capacity, cold chain, safety surveillance | ||||
| 2hesitancy, drop-out, outreach strategies, knowledge, attitudes, practices (KAP) of care provider, community and clients | ||||
| Improving administrative data quality and strengthening data-driven child health program monitoring, action, and accountability and primary health centre (PHC) and district levels (eg, line listing of households with children with neuro-developmental delay (NDD), use of information communication technologies (ICT), develop novel indicators). | 2 | 2 | 24 | 3 |
| Development and validation of low-cost technologies for screening, referral, and management of childhood pneumonia and acute respiratory infection (ARI) in the community and at various levels of health care (eg, mHealth, point-of-care diagnostics & therapeutics, management protocols, etc.). | 3 | 7 | 1 | 20 |
| Strategies to promote water, sanitation, and hygiene practices in the community to improve child health and nutrition. | 4 | 24 | 11 | 2 |
| Development of cost-effective, feasible, validated point-of-care diagnostics for malaria in children for use at community and different levels of health care. | 5 | 4 | 3 | 18 |
| Development of evidence-based guidelines for rational use of antibiotics for childhood morbidities in India: choice of antibiotics; route and delivery systems (eg, nebulizers); duration of therapy; monitoring criteria; adjunct therapies. | 6 | 3 | 19 | 11 |
| Development of an integrated child health program for improving quality of life of children: challenges and barriers; strategies to overcome; feasibility across the country; effectiveness; cost-effectiveness. | 7 | 31 | 7 | 6 |
| Establishing an effective and sustainable VPD surveillance program (especially measles and rubella, pneumonia and diarrhea) in India (eg, defining syndromes (fever and rash) and program thresholds, forging public private partnerships (PPPs), building upon polio infrastructure, using technology such as mHealth, GIS, etc.). | 8 | 22 | 9 | 8 |
| Identifying cost-effective strategies for supplementation of micronutrients and probiotics to prevent and control childhood diarrhea, pneumonia and other infections. | 9 | 30 | 12 | 10 |
| To establish a nation-wide multicentric antimicrobial surveillance and antibiotic stewardship program for infectious morbidities during childhood. | 10 | 23 | 14 | 12 |
| Identifying novel low-cost environmentally friendly strategies for control of vectors. | 11 | 25 | 18 | 7 |
| Strategies to engage the community and its resources (organizations, personnel) in improving the quality and outcome of the community-based management of childhood morbidities. | 12 | 10 | 37 | 9 |
| Identifying barriers and strategies to overcome and achieve Indian Public Health Standards (IPHS) benchmarks at primary and secondary level health facilities. | 13 | 9 | 42 | 14 |
| Identifying effective communication strategies (messages and channels) to improve awareness on child-care and feeding practices during illness. | 14 | 13 | 6 | 33 |
| Impact, process, and economic evaluation of the National Vector Borne Disease Control Program in the context of improving child health. | 15 | 8 | 33 | 28 |
| Epidemiology, risk, and prognostic factors* of childhood pneumonia and ARI and their outcomes (including recurrence) | 16 | 15 | 16 | 30 |
| Impact evaluation of universal immunisation program (UIP) with particular emphasis of recently introduced vaccines (eg, pentavalent measles, supplementary immunisation activities (SIAs), etc.) | 17 | 28 | 51 | 4 |
| Impact of Artemisinin Combination Therapy on malaria disease epidemiology and resistance patterns in India. | 18 | 20 | 5 | 44 |
| Designing vaccination strategies for measles elimination in India in the context of epidemiological dynamics (age at immunization, number of doses, interval between doses, modes of vaccines delivery – routine vs SIA). | 19 | 27 | 17 | 27 |
| Improving diarrhea control strategies in the public health system (eg,, oral rehydration solution (ORS), Zinc, water and sanitation hygiene (WASH), rational antibiotic and drug use). | 20 | 62 | 10 | 5 |
*Biological, genetic, maternal, familial, health, nutrition, socio-cultural, gender, demography, environment, economic, health system related.